ALMS (Alumis) EBIT per Share: $-4.65 (TTM As of Mar. 2026)


ALMS Alumis Inc ALMS
12 GF Score
Price $26.41
! 4 Warning Signs
View Full Analysis

What is Alumis EBIT per Share?

Alumis ALMS +5.52% 12 EBIT per Share is $-4.65 as of Mar. 2026. GuruFocus rates ALMS with a GF Score™ of 12/100. The stock has 4 warning signs investors should review. Among 1,184 Biotechnology companies, Alumis ranks worse than 87.75% on this metric.

Alumis's EBIT per Share for the three months ended in Mar. 2026 was $-0.79. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-4.65.

During the past 3 years, the average EBIT per Share Growth Rate was -21.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Alumis's EBIT per Share or its related term are showing as below:

ALMS' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -21.7   Med: -21.7   Max: -21.7
Current: -21.7

During the past 4 years, the highest 3-Year average EBIT per Share Growth Rate of Alumis was -21.70% per year. The lowest was -21.70% per year. And the median was -21.70% per year.

ALMS's 3-Year EBIT Growth Rate is ranked worse than
87.75% of 1184 companies
in the Biotechnology industry
Industry Median: 15.45 vs ALMS: -21.70

Alumis's EBIT for the three months ended in Mar. 2026 was $-98.41 Mil.

Alumis  (NAS:ALMS) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Alumis EBIT per Share Related Terms

Alumis EBIT per Share Historical Data

* Premium members only.

The historical data trend for Alumis's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alumis EBIT per Share Chart

Alumis Annual Data
Trend Dec22 Dec23 Dec24 Dec25
EBIT per Share
-2.96 -3.05 -10.61 -5.34

Alumis Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.87 -1.84 -1.11 -0.92 -0.79
ALMS
12GF Score
Alumis Inc ALMS
EBIT per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alumis EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Alumis's EBIT per Share for the fiscal year that ended in Dec. 2025 is calculated as

EBIT per Share(A: Dec. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-453.804/85.030
=-5.34

Alumis's EBIT per Share for the quarter that ended in Mar. 2026 is calculated as

EBIT per Share(Q: Mar. 2026 )
=EBIT/Shares Outstanding (Diluted Average)
=-98.409/125.051
=-0.79

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of $-4.65 mean?
Alumis (ALMS) has a EBIT per Share of $-4.65 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Alumis and its competitors. According to the industry distribution chart, Alumis ranks #1039 out of 1184 companies in the Biotechnology industry, placing it in the top 87.8%.
Is Alumis' EBIT per Share too high?
Alumis' current EBIT per Share is $-4.65. Based on the distribution chart, Alumis ranks #1039 out of 1184 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Alumis has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Alumis' EBIT per Share compare to SLNO and ARQT?
According to the Biotechnology industry distribution chart, Alumis ranks #1039 out of 1184 companies for EBIT per Share. This places Alumis in the lower half of its industry. The industry median EBIT per Share is 15.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Biotechnology company?
The median EBIT per Share among Biotechnology companies is 15.45, based on 1,184 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Alumis and its competitors. For the Biotechnology industry, the median EBIT per Share is 15.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alumis's current EBIT per Share is $-4.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alumis stock overvalued right now?
Alumis (ALMS) has a current EBIT per Share of $-4.65. The current EBIT per Share is $-4.65. Alumis' overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Alumis (ALMS), the current EBIT per Share is $-4.65 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alumis Business Description

Address 280 East Grand Avenue, South San Francisco, CA, USA, 94080
Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.
12GF Score

Get the complete analysis for ALMS

EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.41
Price